Jacob Sonenshine is a Reporter at Barron's. He covers a range of topics in finance, including stocks and bonds, investment strategies, and energy trading, with a keen interest in personal finance and alternative investments. Jacob's work has been featured in Financial News, Yahoo Finance, MarketWatch, and several other reputable outlets.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Jacob Sonenshine's coverage primarily focuses on investment analysis, with an emphasis on the stock market and specific sectors such as bank stocks. He frequently cites data in his articles, indicating a preference for fact-based insights.
Given his focus, Jacob would likely be interested in receiving input from financial analysts or experts who can provide detailed and data-driven perspectives on the stock market trends, particularly within small-cap stocks, S&P 500 movements, and bank stocks' performance.
While he doesn't have a specified geographic focus, Jacob predominantly covers the United States’ financial landscape. Therefore, pitches should align with developments relevant to this region unless they have broader global implications.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Biopharmaceutical stocks have emerged winners. Only some will continue to gain.
By: Jacob Sonenshine
Utility stocks have been hit by rising Treasury yields and data-center backlash, but valuations are low and earnings growth remains strong.
By: Jacob Sonenshine
Utility stocks have been hit by rising Treasury yields and data-center backlash, but valuations are low and earnings growth remains strong.
Utility stocks have been hit by rising Treasury yields and data-center backlash, but valuations are low and earnings growth remains strong.
By: Jacob Sonenshine
The stock’s growth story remains intact. We still like the pick.
The stock market typically takes a hit in early fall. We like two sector ETFs whose September dips are regularly bested by their bigger rises in October.
Its growth outlook has improved. Technicals also speak to higher prices.
e.l.f. Beauty's stock took a hard hit shortly after we published our initial recommendation , but the company has flipped the bearish narrative on the business.
By: Jacob Sonenshine
Growth stocks have trailed the rest of the market for months, and the group is beginning to look attractive.
By: Jacob Sonenshine
Growth stocks have been down for months, but there are signals that it’s time for them to move higher again.
